$CRBP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corbus Pharmaceuticals Holdings, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Corbus Pharmaceuticals Holdings, Inc.. Get notifications about new insider transactions in Corbus Pharmaceuticals Holdings, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Jun 17 2021 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 2.07 | 58,200 | 120,474 | 58,200 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 2.58 | 956,500 | 2,467,770 | 956,500 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 2.58 | 956,500 | 2,467,770 | 956,500 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Feb 04 2021 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 2.58 | 307,300 | 792,834 | 307,300 | |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | M | 1.40 | 87,500 | 122,500 | 87,500 | |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | M | 1.00 | 53,610 | 53,610 | 53,610 | |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Sell | S | 1.75 | 87,500 | 153,125 | 349,610 | 437.1 K to 349.6 K (-20.02 %) |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | M | 1.40 | 87,500 | 122,500 | 437,110 | 349.6 K to 437.1 K (+25.03 %) |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Sell | S | 1.40 | 53,610 | 75,054 | 349,610 | 403.2 K to 349.6 K (-13.30 %) |
Dec 22 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | M | 1.00 | 53,610 | 53,610 | 403,220 | 349.6 K to 403.2 K (+15.33 %) |
Dec 18 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | M | 0.17 | 36,923 | 6,118 | 36,923 | |
Dec 18 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Sell | S | 1.32 | 36,923 | 48,628 | 349,610 | 386.5 K to 349.6 K (-9.55 %) |
Dec 18 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | M | 0.17 | 36,923 | 6,118 | 386,533 | 349.6 K to 386.5 K (+10.56 %) |
Jul 08 2020 | CRBP | Corbus Pharmaceuti ... | Golumbeski George | Director | Option Exercise | A | 7.91 | 81,000 | 640,710 | 81,000 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | Jacques Rachelle Suzanne | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
May 22 2020 | CRBP | Corbus Pharmaceuti ... | Salzmann Peter | Director | Option Exercise | A | 7.30 | 40,500 | 295,650 | 40,500 | |
Mar 18 2020 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 4.25 | 2,000 | 8,500 | 12,000 | 10 K to 12 K (+20.00 %) |
Mar 18 2020 | CRBP | Corbus Pharmaceuti ... | Discordia Robert Paul | Chief Operating Off ... | Buy | P | 3.54 | 2,840 | 10,054 | 35,490 | 32.7 K to 35.5 K (+8.70 %) |
Mar 18 2020 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 3.63 | 15,606 | 56,650 | 206,217 | 190.6 K to 206.2 K (+8.19 %) |
Mar 17 2020 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 3.49 | 4,300 | 15,007 | 71,090 | 66.8 K to 71.1 K (+6.44 %) |
Mar 10 2020 | CRBP | Corbus Pharmaceuti ... | Salzmann Peter | Director | Option Exercise | A | 4.53 | 66,600 | 301,698 | 66,600 | |
Mar 09 2020 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 4.53 | 639,000 | 2,894,670 | 639,000 | |
Mar 09 2020 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Option Exercise | A | 4.53 | 226,000 | 1,023,780 | 226,000 | |
Mar 09 2020 | CRBP | Corbus Pharmaceuti ... | Discordia Robert Paul | Chief Operating Off ... | Option Exercise | A | 4.53 | 226,000 | 1,023,780 | 226,000 | |
Mar 09 2020 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 4.53 | 226,000 | 1,023,780 | 226,000 | |
Mar 09 2020 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 4.53 | 226,000 | 1,023,780 | 226,000 | |
Nov 13 2019 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 4.38 | 3,424 | 14,992 | 190,611 | 187.2 K to 190.6 K (+1.83 %) |
Nov 12 2019 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 4.26 | 1,430 | 6,092 | 66,790 | 65.4 K to 66.8 K (+2.19 %) |
Nov 12 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 4.38 | 1,000 | 4,380 | 10,000 | 9 K to 10 K (+11.11 %) |
Nov 12 2019 | CRBP | Corbus Pharmaceuti ... | Discordia Robert Paul | Chief Operating Off ... | Buy | P | 4.62 | 2,500 | 11,559 | 32,650 | 30.2 K to 32.7 K (+8.29 %) |
Aug 16 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 5.48 | 1,500 | 8,213 | 9,000 | 7.5 K to 9 K (+20.00 %) |
Aug 13 2019 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 6.10 | 1,639 | 9,998 | 187,187 | 185.5 K to 187.2 K (+0.88 %) |
Aug 13 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 6.00 | 1,500 | 9,000 | 7,500 | 6 K to 7.5 K (+25.00 %) |
Aug 12 2019 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.06 | 1,175 | 7,116 | 65,360 | 64.2 K to 65.4 K (+1.83 %) |
Aug 12 2019 | CRBP | Corbus Pharmaceuti ... | Discordia Robert Paul | Chief Operating Off ... | Buy | P | 5.86 | 15,000 | 87,894 | 30,150 | 15.2 K to 30.2 K (+99.01 %) |
Aug 08 2019 | CRBP | Corbus Pharmaceuti ... | Discordia Robert Paul | Chief Operating Off ... | Option Exercise | A | 5.64 | 100,000 | 564,000 | 100,000 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | Panayiotopoulos Paris | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | Jacques Rachelle Suzanne | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
Jun 28 2019 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 7.31 | 33,300 | 243,423 | 33,300 | |
May 20 2019 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 7.20 | 1,389 | 10,001 | 185,548 | 184.2 K to 185.5 K (+0.75 %) |
May 15 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 7.23 | 1,000 | 7,227 | 6,000 | 5 K to 6 K (+20.00 %) |
May 14 2019 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 7.12 | 100 | 712 | 349,610 | 349.5 K to 349.6 K (+0.03 %) |
May 14 2019 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.99 | 995 | 6,955 | 64,185 | 63.2 K to 64.2 K (+1.57 %) |
Apr 08 2019 | CRBP | Corbus Pharmaceuti ... | Jacques Rachelle Suzanne | Director | Option Exercise | A | 7.80 | 68,000 | 530,400 | 68,000 | |
Mar 18 2019 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 6.98 | 2,000 | 13,958 | 7,000 | 5 K to 7 K (+40.00 %) |
Mar 15 2019 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Buy | P | 6.98 | 1,000 | 6,978 | 1,000 | 0 to 1,000 |
Mar 15 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Buy | P | 6.85 | 5,000 | 34,259 | 5,000 | 0 to 5 K |
Mar 14 2019 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 6.47 | 4,638 | 29,994 | 184,159 | 179.5 K to 184.2 K (+2.58 %) |
Mar 14 2019 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 6.67 | 1,500 | 10,005 | 349,510 | 348 K to 349.5 K (+0.43 %) |
Mar 14 2019 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.49 | 1,530 | 9,930 | 63,190 | 61.7 K to 63.2 K (+2.48 %) |
Mar 04 2019 | CRBP | Corbus Pharmaceuti ... | Millian Craig Stuart | Chief Commercial Of ... | Option Exercise | A | 6.94 | 180,000 | 1,249,200 | 180,000 | |
Jan 18 2019 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 7.53 | 565,000 | 4,254,450 | 565,000 | |
Jan 18 2019 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 7.53 | 195,000 | 1,468,350 | 195,000 | |
Jan 18 2019 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Option Exercise | A | 7.53 | 195,000 | 1,468,350 | 195,000 | |
Jan 18 2019 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 7.53 | 195,000 | 1,468,350 | 195,000 | |
Nov 16 2018 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Option Exercise | M | 1.00 | 10,000 | 10,000 | 261,600 | |
Nov 16 2018 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Buy | M | 1.00 | 10,000 | 10,000 | 2,110,400 | 2.1 M to 2.1 M (+0.48 %) |
Jun 06 2018 | CRBP | Corbus Pharmaceuti ... | Jenkins John Kenneth | Director | Option Exercise | A | 6.00 | 68,000 | 408,000 | 68,000 | |
May 29 2018 | CRBP | Corbus Pharmaceuti ... | Panayiotopoulos Paris | Director | Option Exercise | A | 5.93 | 34,000 | 201,620 | 34,000 | |
May 29 2018 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 5.93 | 34,000 | 201,620 | 34,000 | |
May 29 2018 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 5.93 | 34,000 | 201,620 | 34,000 | |
May 16 2018 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 5.87 | 2,586 | 15,174 | 179,521 | 176.9 K to 179.5 K (+1.46 %) |
May 16 2018 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 5.85 | 1,725 | 10,091 | 61,660 | 59.9 K to 61.7 K (+2.88 %) |
May 16 2018 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 5.85 | 1,725 | 10,091 | 61,660 | 59.9 K to 61.7 K (+2.88 %) |
May 15 2018 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 5.48 | 5,000 | 27,375 | 5,000 | 0 to 5 K |
May 15 2018 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 5.77 | 4,000 | 23,080 | 348,010 | 344 K to 348 K (+1.16 %) |
Mar 15 2018 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 6.67 | 5,000 | 33,325 | 225,000 | 220 K to 225 K (+2.27 %) |
Mar 15 2018 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 6.89 | 2,885 | 19,878 | 176,935 | 174.1 K to 176.9 K (+1.66 %) |
Mar 15 2018 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.89 | 1,160 | 7,987 | 59,935 | 58.8 K to 59.9 K (+1.97 %) |
Mar 14 2018 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 6.60 | 3,100 | 20,460 | 344,010 | 340.9 K to 344 K (+0.91 %) |
Jan 05 2018 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 8.35 | 175,000 | 1,461,250 | 175,000 | |
Jan 05 2018 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 8.35 | 175,000 | 1,461,250 | 175,000 | |
Jan 05 2018 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Option Exercise | A | 8.35 | 175,000 | 1,461,250 | 175,000 | |
Jan 05 2018 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 8.35 | 175,000 | 1,461,250 | 175,000 | |
Jan 05 2018 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 8.35 | 437,500 | 3,653,125 | 437,500 | |
Nov 17 2017 | CRBP | Corbus Pharmaceuti ... | Panayiotopoulos Paris | Director | Buy | P | 7.03 | 14,285 | 100,392 | 14,285 | 0 to 14.3 K |
Nov 16 2017 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 6.55 | 5,000 | 32,750 | 220,000 | 215 K to 220 K (+2.33 %) |
Nov 14 2017 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Grant | A | 6.90 | 5,000 | 34,500 | 215,000 | 210 K to 215 K (+2.38 %) |
Nov 13 2017 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 7.04 | 1,500 | 10,560 | 340,910 | 339.4 K to 340.9 K (+0.44 %) |
Nov 13 2017 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 7.00 | 2,836 | 19,852 | 174,050 | 171.2 K to 174.1 K (+1.66 %) |
Nov 13 2017 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 7.08 | 10,000 | 70,800 | 459,500 | 449.5 K to 459.5 K (+2.22 %) |
Nov 13 2017 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 7.17 | 1,000 | 7,169 | 58,775 | 57.8 K to 58.8 K (+1.73 %) |
Oct 18 2017 | CRBP | Corbus Pharmaceuti ... | Panayiotopoulos Paris | Director | Option Exercise | A | 6.90 | 61,000 | 420,900 | 61,000 | |
Aug 11 2017 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 6.05 | 2,479 | 14,998 | 171,214 | 168.7 K to 171.2 K (+1.47 %) |
Aug 11 2017 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.00 | 1,695 | 10,170 | 57,775 | 56.1 K to 57.8 K (+3.02 %) |
Aug 11 2017 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 5.91 | 2,500 | 14,775 | 339,410 | 336.9 K to 339.4 K (+0.74 %) |
May 26 2017 | CRBP | Corbus Pharmaceuti ... | GUPTA RENU | Director | Option Exercise | A | 6.75 | 30,500 | 205,875 | 30,500 | |
May 26 2017 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 6.75 | 30,500 | 205,875 | 30,500 | |
May 26 2017 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 6.75 | 30,500 | 205,875 | 30,500 | |
May 26 2017 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Option Exercise | A | 6.75 | 30,500 | 205,875 | 30,500 | |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 6.14 | 3,300 | 20,262 | 336,910 | 333.6 K to 336.9 K (+0.99 %) |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Buy | P | 6.23 | 500 | 3,115 | 22,500 | 22 K to 22.5 K (+2.27 %) |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 6.18 | 3,400 | 21,012 | 459,500 | 456.1 K to 459.5 K (+0.75 %) |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 6.15 | 5,000 | 30,741 | 47,000 | 42 K to 47 K (+11.90 %) |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 6.12 | 2,435 | 14,905 | 168,735 | 166.3 K to 168.7 K (+1.46 %) |
May 12 2017 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 6.01 | 3,250 | 19,539 | 56,080 | 52.8 K to 56.1 K (+6.15 %) |
Mar 20 2017 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 9.49 | 4,233 | 40,171 | 166,300 | 162.1 K to 166.3 K (+2.61 %) |
Mar 17 2017 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | M | 1.00 | 20,000 | 20,000 | 272,728 | |
Mar 17 2017 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | M | 1.00 | 20,000 | 20,000 | 52,830 | 32.8 K to 52.8 K (+60.92 %) |
Mar 13 2017 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 9.60 | 2,000 | 19,200 | 333,610 | 331.6 K to 333.6 K (+0.60 %) |
Mar 03 2017 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Option Exercise | A | 9.05 | 115,000 | 1,040,750 | 115,000 | |
Mar 03 2017 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 9.05 | 115,000 | 1,040,750 | 115,000 | |
Dec 02 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 7.20 | 1,500 | 10,800 | 331,610 | 330.1 K to 331.6 K (+0.45 %) |
Dec 01 2016 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 7.75 | 1,000 | 7,750 | 162,067 | 161.1 K to 162.1 K (+0.62 %) |
Nov 23 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 7.64 | 1,340 | 10,238 | 12,830 | 11.5 K to 12.8 K (+11.66 %) |
Nov 22 2016 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Buy | P | 7.49 | 1,000 | 7,490 | 22,000 | 21 K to 22 K (+4.76 %) |
Nov 22 2016 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Buy | P | 7.55 | 2,000 | 15,100 | 42,000 | 40 K to 42 K (+5.00 %) |
Nov 21 2016 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 7.00 | 10,000 | 69,960 | 456,100 | 446.1 K to 456.1 K (+2.24 %) |
Oct 07 2016 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Option Exercise | A | 8.71 | 150,000 | 1,306,500 | 150,000 | |
Oct 07 2016 | CRBP | Corbus Pharmaceuti ... | Tepper Mark | President and CSO | Option Exercise | A | 8.71 | 150,000 | 1,306,500 | 150,000 | |
Oct 07 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 8.71 | 150,000 | 1,306,500 | 150,000 | |
Oct 07 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 8.71 | 150,000 | 1,306,500 | 150,000 | |
Sep 20 2016 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Option Exercise | A | 7.14 | 50,000 | 357,000 | 50,000 | |
Sep 08 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 5.12 | 30,800 | 157,696 | 330,110 | 299.3 K to 330.1 K (+10.29 %) |
Aug 26 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 3.92 | 17,900 | 70,168 | 299,310 | 281.4 K to 299.3 K (+6.36 %) |
Aug 22 2016 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Buy | P | 3.77 | 1,800 | 6,786 | 456,100 | 454.3 K to 456.1 K (+0.40 %) |
Aug 18 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | M | 1.00 | 20,000 | 20,000 | 292,728 | |
Aug 18 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | M | 1.00 | 20,000 | 20,000 | 31,490 | 11.5 K to 31.5 K (+174.06 %) |
Aug 18 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 3.48 | 65,000 | 226,200 | 281,410 | 216.4 K to 281.4 K (+30.04 %) |
Aug 18 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 3.19 | 83,960 | 267,832 | 216,410 | 132.5 K to 216.4 K (+63.39 %) |
Aug 18 2016 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 3.15 | 38,000 | 119,844 | 161,067 | 123.1 K to 161.1 K (+30.88 %) |
Jun 08 2016 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 3.10 | 1,935 | 5,999 | 123,067 | 121.1 K to 123.1 K (+1.60 %) |
Jun 07 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 3.34 | 1,500 | 5,010 | 11,490 | 10 K to 11.5 K (+15.02 %) |
Jun 02 2016 | CRBP | Corbus Pharmaceuti ... | White Barbara | Chief Medical Offic ... | Buy | P | 3.52 | 2,570 | 9,046 | 121,132 | 118.6 K to 121.1 K (+2.17 %) |
May 31 2016 | CRBP | Corbus Pharmaceuti ... | HOLMER ALAN F | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 31 2016 | CRBP | Corbus Pharmaceuti ... | Hochman David P | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 31 2016 | CRBP | Corbus Pharmaceuti ... | GUPTA RENU | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 31 2016 | CRBP | Corbus Pharmaceuti ... | CATLIN AVERY W | Director | Option Exercise | A | 3.00 | 50,000 | 150,000 | 50,000 | |
May 19 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 2.37 | 27,250 | 64,583 | 132,450 | 105.2 K to 132.5 K (+25.90 %) |
May 19 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Buy | P | 2.40 | 2,125 | 5,100 | 9,990 | 7.9 K to 10 K (+27.02 %) |
May 18 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Buy | P | 2.39 | 30,000 | 71,700 | 105,250 | 75.3 K to 105.3 K (+39.87 %) |
Jan 11 2016 | CRBP | Corbus Pharmaceuti ... | Moran Sean F. | Chief Financial Off ... | Option Exercise | A | 1.40 | 175,000 | 245,000 | 175,000 | |
Jan 11 2016 | CRBP | Corbus Pharmaceuti ... | Cohen Yuval | Chief Executive Off ... | Option Exercise | A | 1.40 | 530,000 | 742,000 | 530,000 |